Compare RAYMED LABS. with KILITCH DRUGS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

RAYMED LABS vs KILITCH DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    RAYMED LABS KILITCH DRUGS RAYMED LABS/
KILITCH DRUGS
 
P/E (TTM) x -5.4 38.3 - View Chart
P/BV x - 1.9 - View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 RAYMED LABS   KILITCH DRUGS
EQUITY SHARE DATA
    RAYMED LABS
Mar-20
KILITCH DRUGS
Mar-21
RAYMED LABS/
KILITCH DRUGS
5-Yr Chart
Click to enlarge
High Rs3139 2.1%   
Low Rs178 1.2%   
Sales per share (Unadj.) Rs044.2 0.0%  
Earnings per share (Unadj.) Rs-0.12.4 -5.4%  
Cash flow per share (Unadj.) Rs-0.13.7 -3.2%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs-4.681.8 -5.7%  
Shares outstanding (eoy) m4.2715.49 27.6%   
Bonus / Rights / Conversions ---  
Price / Sales ratio xNM2.5-  
Avg P/E ratio x-14.844.6 -33.2%  
P/CF ratio (eoy) x-16.629.2 -56.8%  
Price / Book Value ratio x-0.41.3 -31.4%  
Dividend payout %00-   
Avg Mkt Cap Rs m81,679 0.5%   
No. of employees `000NANA-   
Total wages/salary Rs m052 0.3%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m0685 0.0%  
Other income Rs m027 0.5%   
Total revenues Rs m0712 0.0%   
Gross profit Rs m-153 -1.2%  
Depreciation Rs m020 0.3%   
Interest Rs m09 0.0%   
Profit before tax Rs m-151 -1.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m014 0.0%   
Profit after tax Rs m-138 -1.5%  
Gross profit margin %NM7.8- 
Effective tax rate %026.4 0.0%   
Net profit margin %NM5.5- 
BALANCE SHEET DATA
Current assets Rs m1804 0.1%   
Current liabilities Rs m22733 3.1%   
Net working cap to sales %NM10.3- 
Current ratio x01.1 3.7%  
Inventory Days DaysNM333- 
Debtors Days DaysNM1,221- 
Net fixed assets Rs m21,215 0.1%   
Share capital Rs m43155 27.6%   
"Free" reserves Rs m-631,113 -5.6%   
Net worth Rs m-201,268 -1.6%   
Long term debt Rs m00-   
Total assets Rs m32,019 0.1%  
Interest coverage xNM6.8-  
Debt to equity ratio x00-  
Sales to assets ratio x00.3 0.0%   
Return on assets %-21.72.3 -941.8%  
Return on equity %2.83.0 94.5%  
Return on capital %2.84.7 59.3%  
Exports to sales %NM0-  
Imports to sales %NM0-  
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m0189 0.0%   
Fx outflow Rs m049 0.0%   
Net fx Rs m0141 0.0%   
CASH FLOW
From Operations Rs m0457 0.0%  
From Investments Rs mNA-376 0.0%  
From Financial Activity Rs mNA16 0.0%  
Net Cashflow Rs m097 0.0%  

Share Holding

Indian Promoters % 28.4 68.3 41.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 71.6 31.7 226.2%  
Shareholders   1,428 8,740 16.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare RAYMED LABS With:   ANG LIFESCIENCES INDIA  ZOTA HEALTH CARE  SHREE GANESH REMEDIES   BLISS GVS PHARMA  ZIM LABORATORIES  



Today's Market

SGX Nifty Trades Flat, LIC to Raise Stake in Kotak Bank, Tata Chemicals' EV Push, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a positive note yesterday. Benchmark indices trimmed early losses and ended in green backed by IT and healthcare stocks.

Related Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

Don't Sell these Stocks if the Market Falls(Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

How to Find Your Next 10-Bagger in this Market(Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing.(Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

RAYMED LABS SHARE PRICE


Nov 29, 2021 (Close)

TRACK RAYMED LABS

  • Track your investment in RAYMED LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

RAYMED LABS 5-YR ANALYSIS

COMPARE RAYMED LABS WITH

MARKET STATS